A changing spot can be easy to dismiss after a long summer, particularly if it does not hurt. That is exactly why AI mole detection trends deserve careful attention: the technology may help people notice suspicious changes sooner, but it cannot replace a trained clinician examining your skin. For Australians living with some of the world’s highest UV exposure, the safest message is simple: use useful tools, but do not let an app delay a skin check.

Artificial intelligence is increasingly appearing in consumer mobile apps, skin-check clinics, dermoscopy systems and total-body photography services. Some tools compare an image of a mole with large image databases and provide a risk indication. Others help clinicians flag lesions that may deserve a closer look. The opportunity is real, but so are the limits. Skin cancer is not always a dark or textbook-looking mole, and a reassuring screen result is not a diagnosis.

What AI can add to a skin check

AI systems are designed to identify visual patterns. In skin assessment, they may assess features such as asymmetry, uneven borders, colour variation, size and change over time. This can support a clinician’s judgement, especially when many lesions need to be compared or when images from different appointments are available.

The most promising use is not an app declaring that a lesion is harmless. It is AI helping to prioritise attention. A tool may flag a spot for review, assist with image comparison, or support a doctor using dermoscopy, a handheld device that magnifies and illuminates the skin. Used this way, technology can make an organised clinical assessment more efficient without shifting responsibility away from the treating professional.

This matters for people with many moles, a previous melanoma or non-melanoma skin cancer, a strong family history, very fair skin, a history of severe sunburn, or significant occupational sun exposure. For a tradie, farmer, lifeguard or regular outdoor sport participant, small changes can be difficult to track across the back, scalp, ears and other hard-to-see areas. High-quality baseline photography and regular professional review can help create a clearer record.

AI mole detection trends changing Australian skin checks

The direction of travel is towards better documentation, more targeted review and clinician-led decision support. That is useful, provided the technology is introduced with evidence, privacy protections and clear clinical oversight.

From consumer apps to monitored care

A mobile app can make a person more aware of a spot they might otherwise ignore. It can also encourage regular photographs, which may help identify visible change. However, image quality varies enormously. Lighting, focus, skin tone, hair, shadows and camera processing can all affect the result. A close-up image may also miss the wider context a clinician needs, including the person’s age, medical history, other lesions and symptoms.

A consumer app may be a prompt to book, not a reason to stand down. If it says a lesion is low risk but the spot is new, changing, bleeding, itching, sore or simply looks different from your other moles, arrange a clinical assessment. Every minute counts when a concerning lesion is left unexamined.

Total-body photography and change tracking

For higher-risk patients, total-body photography is becoming more relevant. This approach creates a detailed visual record of the skin, allowing clinicians to compare areas over time and identify new or changing lesions. AI may assist by drawing attention to differences between image sets.

This is particularly valuable because melanoma can arise on previously normal-looking skin, not only within an existing mole. Change detection may help pick up a new lesion, but it is not perfect. A photograph is one part of a skin examination. Palpation, dermoscopy, a discussion of symptoms and a clinician’s experience still matter.

AI as clinical decision support

In clinics, AI is more likely to be used alongside dermoscopic images and a clinician’s assessment. Some systems offer a probability score or identify image features associated with particular lesion types. That can be helpful when it prompts a more thorough review or supports referral and biopsy decisions.

It should not be treated as an independent authority. AI can make false-negative errors, where a concerning lesion is missed, and false-positive errors, where a harmless lesion causes alarm. Both outcomes have consequences. A missed melanoma may delay treatment, while too many false alarms can create anxiety and unnecessary procedures. The right balance depends on the person’s risk, the quality of the images and the clinician’s judgement.

More attention to fairness and safety

Many image datasets have historically contained fewer images of darker skin tones and less common presentations. That creates a genuine concern: a tool trained on limited data may perform less reliably for some communities. Skin cancer can occur in people of all skin colours, often in areas that receive less sun exposure, including the soles, palms, nails and mucosal surfaces.

No one should assume they are protected because they have naturally darker skin or do not burn easily. Nor should they rely on an AI result that has not been validated for people like them. Better datasets and transparent testing are needed before claims of accuracy can be trusted across Australia’s diverse population.

What AI cannot tell you

AI cannot examine the whole person. It cannot reliably assess how quickly a lesion has changed, whether it feels tender, whether you have noticed bleeding on your pillowcase, or whether a spot is an “ugly duckling” that looks unlike the rest of your moles. It also cannot replace a biopsy. When a clinician is concerned, removing a sample and examining it under a microscope remains the way to confirm many skin cancer diagnoses.

There is another practical limit: not all skin cancers look like moles. Basal cell carcinomas can appear as a pearly bump, a sore that does not heal or a scaly patch. Squamous cell carcinomas may be crusted, tender or rapidly growing. Melanomas can be flat, raised, pink, red, brown, black, blue or skin-coloured. A tool built around mole images may not be suitable for every lesion.

Be cautious of services that make confident diagnostic claims from a single photo without explaining who reviews the image, how the tool was tested or what happens after a concerning result. In Australia, health technologies and software used for medical purposes may be subject to regulatory requirements. Regardless of marketing language, an online assessment is not a substitute for urgent medical care.

How to use technology without delaying care

Treat AI as one layer of awareness, not your safety net. If you choose to photograph a mole, take a clear image in good light and include a wider photo showing its location. Keep the date, and avoid repeatedly checking it instead of arranging an appointment if there is a genuine concern.

Know the warning signs. The ABCDE guide remains useful: asymmetry, border irregularity, colour variation, diameter and evolution or change. But do not wait for every letter to apply. A spot that is new, changing, growing, bleeding, crusting, itchy or painful needs medical attention. So does a lesion that stands out from the others.

For people at elevated risk, ask a GP, dermatologist or dedicated skin cancer doctor whether regular professional skin checks, dermoscopy or total-body photography are appropriate. The best interval varies. Someone with a past melanoma needs a different follow-up plan from someone with no personal history but substantial sun exposure. A clinician can help set a schedule based on your individual risk rather than a generic reminder.

Continue the prevention measures that reduce the chance of further damage: seek shade, wear protective clothing, use a broad-spectrum SPF50+ sunscreen correctly and reapply it as directed, and protect children from intense UV exposure. Detection technology is not a replacement for prevention.

When to book a skin check now

Book promptly if you have noticed a changing mole or lesion, a sore that has not healed, unexplained bleeding or a spot that looks different from the rest. Do not wait for an app result if you are worried. If a lesion is changing quickly or you cannot access a routine appointment soon, contact a GP or suitable skin-check service for advice about the next available assessment.

AI may make skin surveillance more precise in the years ahead. The life-protective step remains wonderfully straightforward: notice change, take it seriously and let a qualified clinician examine it. Knowledge can save your life, especially when it leads to timely care.